John Simard - 07 Oct 2021 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Queena Han under Power of Attorney for John Simard
Issuer symbol: XBIT
Transactions as of: 07 Oct 2021
Net transactions value: -$1,131,099
Form type: 4
Filing time: 15 Oct 2021, 12:26:50 UTC
Previous filing: 06 Oct 2021
Next filing: 15 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XBIT	Common Stock	Sale	$489,111	-39,286	-0.99%	$12.45	3,923,166	07 Oct 2021	Direct	F1
transaction	XBIT	Common Stock	Sale	$229,939	-18,000	-0.45%	$12.77	3,973,166	12 Oct 2021	Direct	F1
transaction	XBIT	Common Stock	Sale	$139,526	-10,875	-0.27%	$12.83	3,962,452	13 Oct 2021	Direct	F1
transaction	XBIT	Common Stock	Sale	$272,523	-21,125	-0.54%	$12.90	3,873,166	14 Oct 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

John Simard, CEO Chairman of XBiotech, Inc., adopted a stock trading plan. He sold total of 89,286 common stock on the open market as part of this 10B5-1 trading plan.